Ellis IO - Search Results

1

Cytoplasmic Cyclin E Predicts Recurrence in Patients with Breast Cancer.

Hunt KK, Karakas C, Ha MJ, Biernacka A, Yi M, Sahin AA, Adjapong O, Hortobagyi GN, Bondy M, Thompson P, Cheung KL, Ellis IO, Bacus S, Symmans WF, Do KA, Keyomarsi K. Hunt KK, et al. Among authors: ellis io. Clin Cancer Res. 2017 Jun 15;23(12):2991-3002. doi: 10.1158/1078-0432.CCR-16-2217. Epub 2016 Nov 23. Clin Cancer Res. 2017. PMID: 27881578 Free PMC article.

2

Loss of CD55 is associated with aggressive breast tumors.

Madjd Z, Durrant LG, Bradley R, Spendlove I, Ellis IO, Pinder SE. Madjd Z, et al. Among authors: ellis io. Clin Cancer Res. 2004 Apr 15;10(8):2797-803. doi: 10.1158/1078-0432.ccr-1073-03. Clin Cancer Res. 2004. PMID: 15102687

3

Total loss of MHC class I is an independent indicator of good prognosis in breast cancer.

Madjd Z, Spendlove I, Pinder SE, Ellis IO, Durrant LG. Madjd Z, et al. Among authors: ellis io. Int J Cancer. 2005 Nov 1;117(2):248-55. doi: 10.1002/ijc.21163. Int J Cancer. 2005. PMID: 15900607

4

Bcl-2 is a prognostic marker in breast cancer independently of the Nottingham Prognostic Index.

Callagy GM, Pharoah PD, Pinder SE, Hsu FD, Nielsen TO, Ragaz J, Ellis IO, Huntsman D, Caldas C. Callagy GM, et al. Among authors: ellis io. Clin Cancer Res. 2006 Apr 15;12(8):2468-75. doi: 10.1158/1078-0432.CCR-05-2719. Clin Cancer Res. 2006. PMID: 16638854 Free article.

5

The reliability of assessment of oestrogen receptor expression on needle core biopsy specimens of invasive carcinomas of the breast.

Hodi Z, Chakrabarti J, Lee AH, Ronan JE, Elston CW, Cheung KL, Robertson JF, Ellis IO. Hodi Z, et al. Among authors: ellis io. J Clin Pathol. 2007 Mar;60(3):299-302. doi: 10.1136/jcp.2006.036665. Epub 2006 May 26. J Clin Pathol. 2007. PMID: 16731591 Free PMC article. Review.

6

Prognostic markers in triple-negative breast cancer.

Rakha EA, El-Sayed ME, Green AR, Lee AH, Robertson JF, Ellis IO. Rakha EA, et al. Among authors: ellis io. Cancer. 2007 Jan 1;109(1):25-32. doi: 10.1002/cncr.22381. Cancer. 2007. PMID: 17146782 Free article.

7

The p53 positive Bcl-2 negative phenotype is an independent marker of prognosis in breast cancer.

Rolland P, Spendlove I, Madjd Z, Rakha EA, Patel P, Ellis IO, Durrant L. Rolland P, et al. Among authors: ellis io. Int J Cancer. 2007 Mar 15;120(6):1311-7. doi: 10.1002/ijc.22430. Int J Cancer. 2007. PMID: 17187363

8

CCND1 amplification and cyclin D1 expression in breast cancer and their relation with proteomic subgroups and patient outcome.

Elsheikh S, Green AR, Aleskandarany MA, Grainge M, Paish CE, Lambros MB, Reis-Filho JS, Ellis IO. Elsheikh S, et al. Among authors: ellis io. Breast Cancer Res Treat. 2008 May;109(2):325-35. doi: 10.1007/s10549-007-9659-8. Epub 2007 Jul 26. Breast Cancer Res Treat. 2008. PMID: 17653856

9

Biologic and clinical characteristics of breast cancer with single hormone receptor positive phenotype.

Rakha EA, El-Sayed ME, Green AR, Paish EC, Powe DG, Gee J, Nicholson RI, Lee AH, Robertson JF, Ellis IO. Rakha EA, et al. Among authors: ellis io. J Clin Oncol. 2007 Oct 20;25(30):4772-8. doi: 10.1200/JCO.2007.12.2747. Epub 2007 Sep 17. J Clin Oncol. 2007. PMID: 17876012

10

The collagen receptor Endo180 (CD280) Is expressed on basal-like breast tumor cells and promotes tumor growth in vivo.

Wienke D, Davies GC, Johnson DA, Sturge J, Lambros MB, Savage K, Elsheikh SE, Green AR, Ellis IO, Robertson D, Reis-Filho JS, Isacke CM. Wienke D, et al. Among authors: ellis io. Cancer Res. 2007 Nov 1;67(21):10230-40. doi: 10.1158/0008-5472.CAN-06-3496. Cancer Res. 2007. PMID: 17974964

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

771 results

Search Page

Filters